Frank Striebel

1.2k total citations
16 papers, 958 citations indexed

About

Frank Striebel is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Frank Striebel has authored 16 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Genetics. Recurrent topics in Frank Striebel's work include Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (6 papers) and Biochemical and Molecular Research (5 papers). Frank Striebel is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (6 papers) and Biochemical and Molecular Research (5 papers). Frank Striebel collaborates with scholars based in Switzerland, Germany and United States. Frank Striebel's co-authors include Eilika Weber‐Ban, Frank Imkamp, Markus Sutter, Wolfgang Kress, Dennis Özcelik, Heike Summer, Martina Steiner, A. E. Mamedov, Moritz Hunkeler and Peter Sander and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Frank Striebel

16 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Striebel Switzerland	13	753	270	136	103	97	16	958
Vanesa Olivares‐Illana Mexico	20	667 0.9×	343 1.3×	120 0.9×	71 0.7×	80 0.8×	37	1.1k
John C. Timmer United States	9	733 1.0×	222 0.8×	135 1.0×	30 0.3×	34 0.4×	14	1.1k
Mikaela D. Stewart United States	16	780 1.0×	238 0.9×	133 1.0×	39 0.4×	106 1.1×	23	1.1k
Morten Beck Trelle Denmark	16	933 1.2×	116 0.4×	150 1.1×	41 0.4×	82 0.8×	25	1.4k
Serenus Hua United States	23	1.1k 1.4×	87 0.3×	94 0.7×	37 0.4×	129 1.3×	32	1.4k
Brigitte Wiedmann United States	16	779 1.0×	133 0.5×	137 1.0×	42 0.4×	88 0.9×	26	1.1k
Debanu Das United States	14	555 0.7×	97 0.4×	48 0.4×	149 1.4×	95 1.0×	29	743
Evan M. McIntosh Canada	17	1.1k 1.5×	117 0.4×	142 1.0×	125 1.2×	112 1.2×	29	1.3k
Norie Sugitani United States	10	605 0.8×	127 0.5×	59 0.4×	28 0.3×	93 1.0×	15	905
Steve L. Martin United Kingdom	13	375 0.5×	75 0.3×	171 1.3×	72 0.7×	92 0.9×	20	1.0k

Countries citing papers authored by Frank Striebel

Since Specialization

Citations

This map shows the geographic impact of Frank Striebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Striebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Striebel more than expected).

Fields of papers citing papers by Frank Striebel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Striebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Striebel. The network helps show where Frank Striebel may publish in the future.

Co-authorship network of co-authors of Frank Striebel

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Striebel. A scholar is included among the top collaborators of Frank Striebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Striebel. Frank Striebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Staber, Philipp B., Wojciech Jurczak, Richard Greil, et al.. (2021). Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor. Leukemia & lymphoma. 62(14). 3440–3451. 12 indexed citations

Boxhammer, Rainer, Frank Striebel, Roland Baumgartner, & Jan Endell. (2019). Expression of CD19 Antigen on Chronic Lymphocytic Leukemia Cells after Tafasitamab (Anti-CD19) Treatment: Phase I Trial Data. Blood. 134(Supplement_1). 5061–5061. 8 indexed citations

Jurczak, Wojciech, Pier Luigi Zinzani, Gianluca Gaïdano, et al.. (2015). Phase IIa Study of Single-Agent MOR208 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma. Blood. 126(23). 1528–1528. 8 indexed citations

Striebel, Frank, Frank Imkamp, Dennis Özcelik, & Eilika Weber‐Ban. (2013). Pupylation as a signal for proteasomal degradation in bacteria. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(1). 103–113. 57 indexed citations

Delley, Cyrille L., Frank Striebel, Franziska M. Heydenreich, Dennis Özcelik, & Eilika Weber‐Ban. (2011). Activity of the Mycobacterial Proteasomal ATPase Mpa Is Reversibly Regulated by Pupylation. Journal of Biological Chemistry. 287(11). 7907–7914. 32 indexed citations

Striebel, Frank, Moritz Hunkeler, Heike Summer, & Eilika Weber‐Ban. (2010). The mycobacterial Mpa–proteasome unfolds and degrades pupylated substrates by engaging Pup's N‐terminus. The EMBO Journal. 29(7). 1262–1271. 102 indexed citations

Imkamp, Frank, Frank Striebel, Markus Sutter, et al.. (2010). Dop functions as a depupylase in the prokaryotic ubiquitin‐like modification pathway. EMBO Reports. 11(10). 791–797. 83 indexed citations

Imkamp, Frank, Frank Striebel, Peter M. Keller, et al.. (2009). Deletion of dop in Mycobacterium smegmatis abolishes pupylation of protein substrates in vivo. Molecular Microbiology. 75(3). 744–754. 55 indexed citations

Sutter, Markus, Frank Striebel, Fred F. Damberger, Frédéric H.‐T. Allain, & Eilika Weber‐Ban. (2009). A distinct structural region of the prokaryotic ubiquitin‐like protein (Pup) is recognized by the N‐terminal domain of the proteasomal ATPase Mpa. FEBS Letters. 583(19). 3151–3157. 77 indexed citations

10.

Ranjan, Namit, Wolfgang Kress, Frank Striebel, et al.. (2009). Studying chaperone–proteases using a real-time approach based on FRET. Journal of Structural Biology. 168(2). 267–277. 19 indexed citations

11.

Striebel, Frank, Frank Imkamp, Markus Sutter, et al.. (2009). Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes. Nature Structural & Molecular Biology. 16(6). 647–651. 162 indexed citations

12.

Striebel, Frank, Wolfgang Kress, & Eilika Weber‐Ban. (2009). Controlled destruction: AAA+ ATPases in protein degradation from bacteria to eukaryotes. Current Opinion in Structural Biology. 19(2). 209–217. 103 indexed citations

13.

Maglica, Željka, Frank Striebel, & Eilika Weber‐Ban. (2008). An Intrinsic Degradation Tag on the ClpA C-Terminus Regulates the Balance of ClpAP Complexes with Different Substrate Specificity. Journal of Molecular Biology. 384(2). 503–511. 34 indexed citations

14.

Papp, Laura V., Jun Lu, Frank Striebel, et al.. (2006). The Redox State of SECIS Binding Protein 2 Controls Its Localization and Selenocysteine Incorporation Function. Molecular and Cellular Biology. 26(13). 4895–4910. 78 indexed citations

15.

Lehmann, Michael H., Stefan Walter, Loyda Ylisastigui, et al.. (2006). Extracellular HIV-1 Nef increases migration of monocytes. Experimental Cell Research. 312(18). 3659–3668. 22 indexed citations

16.

Hammer, Michael, Jörg Mages, Frank Schmitz, et al.. (2005). Control of dual‐specificity phosphatase‐1 expression in activated macrophages by IL‐10. European Journal of Immunology. 35(10). 2991–3001. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact